Ibuzatrelvir
id:
ibuzatrelvir-173-3331920
title:
Ibuzatrelvir
text:
Ibuzatrelvir is an experimental antiviral drug being developed by Pfizer for the treatment of COVID-19. It is a second-generation improvement over nirmatrelvir which has a similar chemical structure. One of the disadvantages of nirmatrelvir is that it has low metabolic stability and must be given in combination with ritonavir to limit its metabolic degradation in the body. Ibuzatrelvir incorporates modifications to the chemical structure of nirmatrelvir that give it enhanced oral bioavailability
brand slug:
wiki
category slug:
encyclopedia
description:
Antiviral drug
original url:
https://en.wikipedia.org/wiki/Ibuzatrelvir
date created:
2024-08-15T17:06:48Z
date modified:
2024-09-02T05:42:57Z
main entity:
{"identifier":"Q127415685","url":"https://www.wikidata.org/entity/Q127415685"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/d/d8/Ibuzatrelvir.svg","width":855,"height":520}
fields total:
13
integrity:
16